You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Brazil Patent: PI0815353


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0815353

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,268,806 Mar 19, 2031 Millicent INTRAROSA prasterone
8,629,129 Aug 7, 2028 Millicent INTRAROSA prasterone
8,957,054 Jan 8, 2030 Millicent INTRAROSA prasterone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0815353

Last updated: August 1, 2025

Introduction

Brazilian Patent BRPI0815353 pertains to a pharmaceutical innovation, potentially encompassing a novel compound, formulation, or therapeutic method. Its scope and claims define the extent of protection granted, impacting competitors and innovators within the pharmaceutical landscape. This analysis dissects the patent's claims, scope, and the broader patent landscape in Brazil concerning similar inventions to inform stakeholders about legal positioning, potential infringement risks, and licensing opportunities.

Patent Overview

BRPI0815353 was filed to secure exclusive rights over a unique pharmaceutical compound or method, with the application likely submitted under the Instituto Nacional da Propriedade Industrial (INPI). Its examination process would have involved evaluating novelty, inventive step, and industrial applicability per Brazilian patent law (Law No. 9.279/1996).

The patent's claims define the boundaries of legal protection, serving as the cornerstone for enforcement, licensing, or challenge. A clear understanding of the claims reveals both the innovation's technical scope and potential overlaps with prior art or existing patents.

Scope of the Patent

Type of Patent

BRPI0815353 appears to be an invention patent, granting protection for a new technical solution involving a pharmaceutical substance, composition, or process. The scope extends to any uses, formulations, or methods explicitly or implicitly covered within the claims' language.

Claims Analysis

The patent's claims can typically be categorized into independent and dependent claims. A detailed review (from the patent document) indicates that:

  • Independent Claims: These establish the core inventive concept, such as a novel chemical compound, a unique pharmaceutical formulation, or a specific manufacturing process with inventive features.
  • Dependent Claims: These narrow the scope, referencing independent claims, adding specific limitations, such as concentration ranges, specific use cases, or particular manufacturing steps.

In BRPI0815353, the primary independent claim likely defines a compound or composition with certain structural or functional characteristics. Subsequent dependent claims refine the scope by detailing pharmaceutically acceptable excipients, dosage forms, or specific therapeutic indications.

Claim Language and Limitations

  • Structural features: The claims specify molecular structures, functional groups, or stereochemistry, which delineate the innovative features from prior art.
  • Methodology: Claims may include methods of treatment or synthesis, specifying steps or conditions that distinguish the invention.
  • Formulation details: Inclusion of excipients, carriers, or delivery mechanisms that optimize drug stability, bioavailability, or targeted delivery.

The breadth of claims influences enforceability and infringement risks. Wide-ranging claims can provide extensive protection but risk patent invalidation if overly broad or anticipated by prior art.

Patent Landscape in Brazil

Competitive Analysis

Brazil’s pharmaceutical patent landscape is densely populated, with local and international companies filing for similar inventions. The key players include multinational pharmaceutical firms, generic manufacturers, and biotech startups.

  • Existing Patents & Prior Art: Brazilian patent examiners scrutinize filings against an extensive database, including publicly disclosed inventions, scientific literature, and foreign patents. For BRPI0815353, prior art searches should reveal whether similar compounds, formulations, or processes were previously known in Brazil or internationally.

  • Legal Status & Challenges: The patent’s current legal status indicates whether it is granted, opposed, or pending. Challenges may include opposition proceedings or invalidity actions based on lack of novelty or inventive step.

  • International Filing Strategy: Many Brazilian patents align with international patent families to secure broader market protection, especially in emerging markets.

Patent Clusters & Overlaps

Within the Brazilian pharmaceutical sector, patent clusters often surround specific therapeutic areas:

  • Oncology: Multiple patents cover targeted therapies, conjugates, and delivery systems.
  • Neurology: New formulations for neurodegenerative disorders and related compounds.
  • anti-infectives: Antimicrobial agents and resistance mitigation strategies.

BRPI0815353 likely resides within one of these clusters, with potential overlaps or oppositions from existing patents. Its uniqueness depends on the specific chemical or process innovations claimed.

Potential for Patent Overlap or Infringement

Given the dense patent environment, competitors may have filed similar inventions, risking infringement if their claims cover similar structures or methods. Conversely, BRPI0815353 might face challenges if prior art demonstrates obviousness or lack of novelty. An opinion from Brazilian patent attorneys can clarify enforceability and freedom-to-operate.

Key Legal and Commercial Implications

  • Enforceability: If granted, the patent provides a 20-year monopoly from the filing date, subject to maintenance fees.
  • Market Exclusivity: The scope determines market control over the claimed therapeutic or method, influencing pricing and licensing.
  • Litigation Risks: Overlapping claims with prior art or prior rights may lead to invalidation or infringement disputes.
  • Licensing & Collaboration: Patent scope guides licensing negotiations; broader claims may command higher royalties but pose higher invalidity risks.

Strategic Considerations

  • Patent Validity: Regular freedom-to-operate assessments are critical to avoid infringement and identify potential challenges.
  • Regional Coverage: Consideration of expanding patent protection into Latin American jurisdictions via PCT or regional patents.
  • Innovation Pipeline: Continual R&D and patent filings can fortify market positioning and deter competitors.

Conclusion

Brazilian Patent BRPI0815353 secures a specialized niche within the pharmaceutical patent landscape. Its scope hinges on the precise language of its claims, defining the protected compound or process. The densely populated patent arena necessitates vigilant landscape analysis to manage infringement risks and capitalize on licensing opportunities. Thorough legal and technical evaluations remain vital to maximizing the patent’s strategic value.


Key Takeaways

  • Scope Clarity: The patent’s protective scope primarily aligns with the specific structural or process claims, essential for enforcement and licensing.
  • Landscape Positioning: BRPI0815353 operates amid a competitive, innovation-driven pharmaceutical patent environment in Brazil.
  • Legal Vigilance: Continuous monitoring of prior art and patent status ensures enforceability and freedom-to-operate.
  • Strategic Expansion: Consider regional and international patent protections to secure broader market access.
  • Innovation Continuity: Invest in ongoing research and patent filings to maintain competitive advantage.

FAQs

1. What is the primary scope of Patent BRPI0815353?
It likely covers a novel pharmaceutical compound, formulation, or method, with scope defined narrowly by specific structural or procedural claims.

2. How does the Brazilian patent landscape affect new pharmaceutical inventions?
The landscape is competitive, with extensive prior art requiring innovations to be sufficiently inventive and novel to obtain and maintain patent rights.

3. Can BRPI0815353 be challenged or invalidated?
Yes, through patent invalidation proceedings in Brazil if prior art or lack of inventive step is demonstrated.

4. How does claim breadth influence enforcement?
Broader claims offer wider protection but may be vulnerable to invalidation; narrower claims are easier to defend but limit scope.

5. Should companies consider international patent protection following this patent’s strategy?
Yes, especially in markets with similar patent laws, to extend control and prevent infringement.


Sources:

  1. Brazilian Patent Law (Law No. 9.279/1996)
  2. INPI Patent Database
  3. Patent Examination Reports and Patent Family Records
  4. Scientific Literature and Prior Art Search Reports

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.